Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals Announces Promotion of Robert Gallotto to Chief Business Officer
May 8th, 2009
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced the promotion of Robert Gallotto to chief business officer. This appointment reflects Alnara’s growing operations as the company prepares to submit a new drug application (NDA) and commercialize liprotamase, a novel, oral, porcine-free pancreatic enzyme replacement therapy (PERT) that has already completed a Phase 3 efficacy trial. Mr. Gallotto brings to his new role over 20 years of pharmaceutical industry experience, with a focus on strategic planning, commercial and business development, and...
Source: Health Business Week (2009-05-08)
|
